

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.20497032 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.03957770 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.97307926 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.88751772 |
| 5 | vocalization behavior (GO:0071625) | 4.80316936 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.60616398 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.43382714 |
| 8 | protein localization to synapse (GO:0035418) | 4.33870109 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.32729725 |
| 10 | nucleobase catabolic process (GO:0046113) | 4.23883660 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.22815974 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.15891413 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.11455595 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 4.07927507 |
| 15 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.07927507 |
| 16 | glutamate secretion (GO:0014047) | 4.03861323 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.97194794 |
| 18 | behavioral response to nicotine (GO:0035095) | 3.94774159 |
| 19 | synaptic vesicle maturation (GO:0016188) | 3.94111023 |
| 20 | neurotransmitter secretion (GO:0007269) | 3.94108325 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.85982697 |
| 22 | neuron recognition (GO:0008038) | 3.77374408 |
| 23 | locomotory exploration behavior (GO:0035641) | 3.72236946 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.65043465 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.62407880 |
| 26 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.62038167 |
| 27 | regulation of glutamate secretion (GO:0014048) | 3.61850244 |
| 28 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.57374752 |
| 29 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.57374752 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.53304104 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.52392418 |
| 32 | establishment of mitochondrion localization (GO:0051654) | 3.52170203 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.51454451 |
| 34 | regulation of protein kinase A signaling (GO:0010738) | 3.51371727 |
| 35 | neurofilament cytoskeleton organization (GO:0060052) | 3.49043396 |
| 36 | neurotransmitter transport (GO:0006836) | 3.48885033 |
| 37 | mating behavior (GO:0007617) | 3.48204711 |
| 38 | presynaptic membrane assembly (GO:0097105) | 3.48203822 |
| 39 | exploration behavior (GO:0035640) | 3.46138665 |
| 40 | positive regulation of synapse assembly (GO:0051965) | 3.45428598 |
| 41 | dopamine biosynthetic process (GO:0042416) | 3.45215693 |
| 42 | respiratory electron transport chain (GO:0022904) | 3.44911676 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 3.43127547 |
| 44 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.42461249 |
| 45 | electron transport chain (GO:0022900) | 3.39772253 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.37060827 |
| 47 | response to histamine (GO:0034776) | 3.36960974 |
| 48 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.36668635 |
| 49 | regulation of vesicle fusion (GO:0031338) | 3.36452311 |
| 50 | chaperone-mediated protein transport (GO:0072321) | 3.33461328 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.33338622 |
| 52 | proline transport (GO:0015824) | 3.30921387 |
| 53 | synaptic transmission, glutamatergic (GO:0035249) | 3.30529416 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.28809322 |
| 55 | regulation of neurotransmitter levels (GO:0001505) | 3.26444003 |
| 56 | dendritic spine morphogenesis (GO:0060997) | 3.22058102 |
| 57 | protein complex biogenesis (GO:0070271) | 3.21351978 |
| 58 | detection of calcium ion (GO:0005513) | 3.21148370 |
| 59 | presynaptic membrane organization (GO:0097090) | 3.19537241 |
| 60 | dopamine transport (GO:0015872) | 3.18001270 |
| 61 | neuromuscular process controlling posture (GO:0050884) | 3.16665486 |
| 62 | axonal fasciculation (GO:0007413) | 3.14663906 |
| 63 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.13896989 |
| 64 | regulation of dopamine metabolic process (GO:0042053) | 3.13343317 |
| 65 | regulation of catecholamine metabolic process (GO:0042069) | 3.13343317 |
| 66 | transferrin transport (GO:0033572) | 3.13231761 |
| 67 | auditory behavior (GO:0031223) | 3.13187535 |
| 68 | regulation of postsynaptic membrane potential (GO:0060078) | 3.11122330 |
| 69 | negative regulation of microtubule polymerization (GO:0031115) | 3.11046672 |
| 70 | synaptic transmission, dopaminergic (GO:0001963) | 3.10544836 |
| 71 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.10158047 |
| 72 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.09741143 |
| 73 | gamma-aminobutyric acid transport (GO:0015812) | 3.09689687 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.07235908 |
| 75 | layer formation in cerebral cortex (GO:0021819) | 3.07024358 |
| 76 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.06894869 |
| 77 | synapse assembly (GO:0007416) | 3.05318994 |
| 78 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.02704843 |
| 79 | catecholamine transport (GO:0051937) | 3.02548465 |
| 80 | synaptic vesicle transport (GO:0048489) | 2.98932532 |
| 81 | establishment of synaptic vesicle localization (GO:0097480) | 2.98932532 |
| 82 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.98475394 |
| 83 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98054970 |
| 84 | protein localization to cilium (GO:0061512) | 2.97699702 |
| 85 | regulation of synapse structural plasticity (GO:0051823) | 2.96023734 |
| 86 | membrane hyperpolarization (GO:0060081) | 2.95604192 |
| 87 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.94495687 |
| 88 | mitochondrion transport along microtubule (GO:0047497) | 2.94495687 |
| 89 | activation of protein kinase A activity (GO:0034199) | 2.94259699 |
| 90 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.93396482 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91255718 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.91060508 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91030130 |
| 94 | positive regulation of membrane potential (GO:0045838) | 2.91007649 |
| 95 | positive regulation of amino acid transport (GO:0051957) | 2.90685312 |
| 96 | trivalent inorganic cation transport (GO:0072512) | 2.90502355 |
| 97 | ferric iron transport (GO:0015682) | 2.90502355 |
| 98 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.89251316 |
| 99 | behavioral response to cocaine (GO:0048148) | 2.88691769 |
| 100 | righting reflex (GO:0060013) | 2.88162787 |
| 101 | intraspecies interaction between organisms (GO:0051703) | 2.87964999 |
| 102 | social behavior (GO:0035176) | 2.87964999 |
| 103 | regulation of neurotransmitter secretion (GO:0046928) | 2.87372932 |
| 104 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.86828224 |
| 105 | female mating behavior (GO:0060180) | 2.85584373 |
| 106 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.84901384 |
| 107 | neurotransmitter catabolic process (GO:0042135) | 2.83873226 |
| 108 | long-term synaptic potentiation (GO:0060291) | 2.82566096 |
| 109 | mechanosensory behavior (GO:0007638) | 2.82179669 |
| 110 | fear response (GO:0042596) | 2.81884236 |
| 111 | innervation (GO:0060384) | 2.81596764 |
| 112 | synaptic transmission (GO:0007268) | 2.80431630 |
| 113 | prepulse inhibition (GO:0060134) | 2.80158393 |
| 114 | striatum development (GO:0021756) | 2.79229804 |
| 115 | startle response (GO:0001964) | 2.79182002 |
| 116 | NADH dehydrogenase complex assembly (GO:0010257) | 2.78095439 |
| 117 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.78095439 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.78095439 |
| 119 | cell migration in hindbrain (GO:0021535) | 2.77757382 |
| 120 | nonmotile primary cilium assembly (GO:0035058) | 2.74636336 |
| 121 | retinal ganglion cell axon guidance (GO:0031290) | 2.72718268 |
| 122 | neuromuscular synaptic transmission (GO:0007274) | 2.70902777 |
| 123 | neuronal ion channel clustering (GO:0045161) | 2.67667467 |
| 124 | membrane depolarization during action potential (GO:0086010) | 2.67196663 |
| 125 | regulation of respiratory system process (GO:0044065) | 2.65003950 |
| 126 | neuronal action potential (GO:0019228) | 2.63317821 |
| 127 | protein neddylation (GO:0045116) | 2.60273531 |
| 128 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.58243895 |
| 129 | respiratory chain complex IV assembly (GO:0008535) | 2.58169281 |
| 130 | behavioral fear response (GO:0001662) | 2.58156405 |
| 131 | behavioral defense response (GO:0002209) | 2.58156405 |
| 132 | adult walking behavior (GO:0007628) | 2.57278238 |
| 133 | response to auditory stimulus (GO:0010996) | 2.55094822 |
| 134 | sequestering of actin monomers (GO:0042989) | 2.55062363 |
| 135 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.55038437 |
| 136 | response to amphetamine (GO:0001975) | 2.54006985 |
| 137 | brain morphogenesis (GO:0048854) | 2.52388944 |
| 138 | regulation of feeding behavior (GO:0060259) | 2.50049329 |
| 139 | adult behavior (GO:0030534) | 2.49302655 |
| 140 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.49093633 |
| 141 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.49093633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.28933415 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.57304819 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10366172 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97853963 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94398091 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78304608 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.73009507 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.66853868 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.65547869 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61868102 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.57325824 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.52636880 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51197059 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50730232 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46484771 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46484771 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36378473 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33961707 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.33678939 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.31711983 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.30472412 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29657885 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.16208934 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16015470 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14021922 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11941974 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96896620 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96532208 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95083426 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92052516 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90612426 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82119966 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81108882 |
| 34 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.74456528 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73436817 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72567964 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66381151 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66335394 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66302169 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64595047 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60674714 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58308063 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55882256 |
| 44 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54810132 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51065535 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50964203 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49682706 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48850178 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47285292 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46172931 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46132268 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44434755 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37226681 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36506543 |
| 55 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.35717095 |
| 56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34684718 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33501584 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30783592 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28060689 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25883854 |
| 61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.24763239 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24432690 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23368091 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22511971 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22327306 |
| 66 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22299613 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22029727 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21670929 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.21581179 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21501747 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.21333843 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21164382 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17578042 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16432063 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16227840 |
| 76 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.15586387 |
| 77 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.14797330 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13008244 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12937907 |
| 80 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11024540 |
| 81 | JUN_21703547_ChIP-Seq_K562_Human | 1.10434719 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10213109 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09897936 |
| 84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08691786 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04541555 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02232765 |
| 87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00669758 |
| 88 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99644532 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99283375 |
| 90 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98464691 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98358231 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97466834 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97036716 |
| 94 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96839624 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96149379 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93544900 |
| 97 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93357598 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92500172 |
| 99 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92474954 |
| 100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92257897 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91551793 |
| 102 | AR_19668381_ChIP-Seq_PC3_Human | 0.90975845 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90864271 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90750648 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90428861 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89406201 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89052756 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89042755 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87020522 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87020522 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86957012 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86957012 |
| 113 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.86897595 |
| 114 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86817404 |
| 115 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85482155 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85122851 |
| 117 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.84194364 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84016153 |
| 119 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83596669 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.81988500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.77975628 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.09920114 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.42344938 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.31103174 |
| 5 | MP0003122_maternal_imprinting | 3.09601902 |
| 6 | MP0009745_abnormal_behavioral_response | 3.01917476 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.95733631 |
| 8 | MP0004270_analgesia | 2.87537799 |
| 9 | MP0001529_abnormal_vocalization | 2.85294425 |
| 10 | MP0002064_seizures | 2.83173522 |
| 11 | MP0009046_muscle_twitch | 2.80694156 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.76367047 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.67876999 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.65006915 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.49992252 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.47193383 |
| 17 | MP0002822_catalepsy | 2.44780124 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.44271958 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.41718381 |
| 20 | MP0002736_abnormal_nociception_after | 2.38747021 |
| 21 | MP0002272_abnormal_nervous_system | 2.37261061 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.35033162 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.24214890 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.22571364 |
| 25 | MP0001905_abnormal_dopamine_level | 2.13429979 |
| 26 | MP0001486_abnormal_startle_reflex | 2.10188955 |
| 27 | MP0001970_abnormal_pain_threshold | 2.02260766 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.96788455 |
| 29 | MP0002184_abnormal_innervation | 1.93873080 |
| 30 | MP0001984_abnormal_olfaction | 1.90624269 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.90189298 |
| 32 | MP0004924_abnormal_behavior | 1.90175541 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.90175541 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.84357140 |
| 35 | MP0004142_abnormal_muscle_tone | 1.75974062 |
| 36 | MP0000778_abnormal_nervous_system | 1.74573229 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.73464421 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.71944555 |
| 39 | MP0004133_heterotaxia | 1.54216080 |
| 40 | MP0001188_hyperpigmentation | 1.53197864 |
| 41 | MP0002102_abnormal_ear_morphology | 1.50175329 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.48418455 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.47914193 |
| 44 | MP0003787_abnormal_imprinting | 1.45510751 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.44491571 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.37883803 |
| 47 | MP0000955_abnormal_spinal_cord | 1.36836017 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.35961886 |
| 49 | MP0003121_genomic_imprinting | 1.33093927 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.33022730 |
| 51 | MP0003329_amyloid_beta_deposits | 1.30458812 |
| 52 | MP0002066_abnormal_motor_capabilities/c | 1.29513735 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.28904865 |
| 54 | MP0000631_abnormal_neuroendocrine_gland | 1.28003456 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.27720912 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.24721803 |
| 57 | MP0004858_abnormal_nervous_system | 1.24080760 |
| 58 | MP0008569_lethality_at_weaning | 1.16224478 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.14669986 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.14338848 |
| 61 | MP0000751_myopathy | 1.13635606 |
| 62 | MP0003123_paternal_imprinting | 1.11422134 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.09473800 |
| 64 | MP0004742_abnormal_vestibular_system | 1.06653240 |
| 65 | MP0008872_abnormal_physiological_respon | 1.05333202 |
| 66 | MP0003879_abnormal_hair_cell | 1.04502786 |
| 67 | MP0005394_taste/olfaction_phenotype | 1.03923190 |
| 68 | MP0005499_abnormal_olfactory_system | 1.03923190 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.03821386 |
| 70 | MP0002751_abnormal_autonomic_nervous | 1.03753210 |
| 71 | MP0002152_abnormal_brain_morphology | 1.02065870 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 1.00195415 |
| 73 | MP0005535_abnormal_body_temperature | 0.99325395 |
| 74 | MP0003890_abnormal_embryonic-extraembry | 0.98408275 |
| 75 | MP0003011_delayed_dark_adaptation | 0.97407707 |
| 76 | MP0002163_abnormal_gland_morphology | 0.96385293 |
| 77 | MP0002938_white_spotting | 0.94691520 |
| 78 | MP0002229_neurodegeneration | 0.91813431 |
| 79 | MP0008995_early_reproductive_senescence | 0.91301686 |
| 80 | MP0002752_abnormal_somatic_nervous | 0.90780974 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.88034867 |
| 82 | MP0003283_abnormal_digestive_organ | 0.84694470 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.84544315 |
| 84 | MP0003195_calcinosis | 0.83730379 |
| 85 | MP0001664_abnormal_digestion | 0.82341875 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.82311108 |
| 87 | MP0003633_abnormal_nervous_system | 0.82034254 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.81315014 |
| 89 | MP0004085_abnormal_heartbeat | 0.81134310 |
| 90 | MP0004885_abnormal_endolymph | 0.79963014 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.79089904 |
| 92 | MP0005253_abnormal_eye_physiology | 0.78143095 |
| 93 | MP0009379_abnormal_foot_pigmentation | 0.78052565 |
| 94 | MP0000566_synostosis | 0.77798001 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.75991221 |
| 96 | MP0005187_abnormal_penis_morphology | 0.75176469 |
| 97 | MP0001944_abnormal_pancreas_morphology | 0.74834046 |
| 98 | MP0003631_nervous_system_phenotype | 0.74456735 |
| 99 | MP0002090_abnormal_vision | 0.72425586 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.71767723 |
| 101 | MP0003119_abnormal_digestive_system | 0.70228526 |
| 102 | MP0003634_abnormal_glial_cell | 0.69950342 |
| 103 | MP0005195_abnormal_posterior_eye | 0.69604271 |
| 104 | MP0002928_abnormal_bile_duct | 0.68533062 |
| 105 | MP0008789_abnormal_olfactory_epithelium | 0.65954603 |
| 106 | MP0001943_abnormal_respiration | 0.65769575 |
| 107 | MP0002234_abnormal_pharynx_morphology | 0.65301962 |
| 108 | MP0005409_darkened_coat_color | 0.65236547 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.64751490 |
| 110 | MP0000026_abnormal_inner_ear | 0.64711866 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.62553039 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.59292824 |
| 113 | MP0004043_abnormal_pH_regulation | 0.58838417 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.56035076 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.54539054 |
| 116 | MP0003861_abnormal_nervous_system | 0.53943679 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.53154481 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.52466324 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.52280015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.79036349 |
| 2 | Myokymia (HP:0002411) | 5.32267039 |
| 3 | Visual hallucinations (HP:0002367) | 4.63150326 |
| 4 | Limb dystonia (HP:0002451) | 4.55924984 |
| 5 | Atonic seizures (HP:0010819) | 4.55822559 |
| 6 | Focal seizures (HP:0007359) | 4.47840400 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.28559330 |
| 8 | Epileptic encephalopathy (HP:0200134) | 3.96411767 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.91245330 |
| 10 | Absence seizures (HP:0002121) | 3.89763197 |
| 11 | Febrile seizures (HP:0002373) | 3.83902988 |
| 12 | Progressive macrocephaly (HP:0004481) | 3.78989376 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.58657058 |
| 14 | Pheochromocytoma (HP:0002666) | 3.54376974 |
| 15 | Dialeptic seizures (HP:0011146) | 3.49009447 |
| 16 | Failure to thrive in infancy (HP:0001531) | 3.40419165 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.36729214 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.34697326 |
| 19 | Neuroendocrine neoplasm (HP:0100634) | 3.24926002 |
| 20 | Hypothermia (HP:0002045) | 3.20005749 |
| 21 | Acute encephalopathy (HP:0006846) | 3.18930085 |
| 22 | Polyphagia (HP:0002591) | 3.17776422 |
| 23 | Gait imbalance (HP:0002141) | 3.03858089 |
| 24 | Abnormal hair whorl (HP:0010721) | 3.03641338 |
| 25 | Amblyopia (HP:0000646) | 2.91041868 |
| 26 | Anxiety (HP:0000739) | 2.90846362 |
| 27 | Abnormal eating behavior (HP:0100738) | 2.72508658 |
| 28 | Hyperventilation (HP:0002883) | 2.71138489 |
| 29 | Congenital primary aphakia (HP:0007707) | 2.69948421 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 2.68737375 |
| 31 | Pancreatic fibrosis (HP:0100732) | 2.67419976 |
| 32 | Nephronophthisis (HP:0000090) | 2.66265671 |
| 33 | Increased CSF lactate (HP:0002490) | 2.65064628 |
| 34 | Broad-based gait (HP:0002136) | 2.63882427 |
| 35 | Poor suck (HP:0002033) | 2.63250799 |
| 36 | Agitation (HP:0000713) | 2.62878873 |
| 37 | Truncal ataxia (HP:0002078) | 2.61145004 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.57155298 |
| 39 | Progressive inability to walk (HP:0002505) | 2.56796631 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.53228353 |
| 41 | Hypoventilation (HP:0002791) | 2.52898947 |
| 42 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49126799 |
| 43 | Pancreatic cysts (HP:0001737) | 2.49038151 |
| 44 | Optic disc pallor (HP:0000543) | 2.47750810 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.44828868 |
| 46 | Genital tract atresia (HP:0001827) | 2.38584080 |
| 47 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.37936334 |
| 48 | Vaginal atresia (HP:0000148) | 2.36437223 |
| 49 | Depression (HP:0000716) | 2.34357076 |
| 50 | Esotropia (HP:0000565) | 2.34313565 |
| 51 | Hypsarrhythmia (HP:0002521) | 2.34152759 |
| 52 | True hermaphroditism (HP:0010459) | 2.33191257 |
| 53 | Hepatic necrosis (HP:0002605) | 2.33054677 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.31356724 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.30887138 |
| 56 | Oligomenorrhea (HP:0000876) | 2.29260153 |
| 57 | Hepatocellular necrosis (HP:0001404) | 2.27481482 |
| 58 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.26929870 |
| 59 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.26929870 |
| 60 | Methylmalonic acidemia (HP:0002912) | 2.24475195 |
| 61 | Specific learning disability (HP:0001328) | 2.24191280 |
| 62 | Ankle clonus (HP:0011448) | 2.24148331 |
| 63 | Drooling (HP:0002307) | 2.23016633 |
| 64 | Excessive salivation (HP:0003781) | 2.23016633 |
| 65 | Hyperthyroidism (HP:0000836) | 2.21188215 |
| 66 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.20141159 |
| 67 | Abnormal ciliary motility (HP:0012262) | 2.19967530 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17210872 |
| 69 | Psychosis (HP:0000709) | 2.12046142 |
| 70 | Action tremor (HP:0002345) | 2.10570022 |
| 71 | Gaze-evoked nystagmus (HP:0000640) | 2.08311186 |
| 72 | Abnormality of the labia minora (HP:0012880) | 2.08201076 |
| 73 | Lissencephaly (HP:0001339) | 2.08068632 |
| 74 | Abnormality of the renal medulla (HP:0100957) | 2.05490644 |
| 75 | Leukodystrophy (HP:0002415) | 2.04899151 |
| 76 | Muscular hypotonia of the trunk (HP:0008936) | 2.04808826 |
| 77 | Postural tremor (HP:0002174) | 1.99441731 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 1.99274842 |
| 79 | Hemiparesis (HP:0001269) | 1.99143093 |
| 80 | Increased hepatocellular lipid droplets (HP:0006565) | 1.98472050 |
| 81 | Type II lissencephaly (HP:0007260) | 1.97934363 |
| 82 | Status epilepticus (HP:0002133) | 1.97894358 |
| 83 | Narrow nasal bridge (HP:0000446) | 1.97730931 |
| 84 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.96942745 |
| 85 | Abnormal pupillary function (HP:0007686) | 1.96725231 |
| 86 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95788090 |
| 87 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95788090 |
| 88 | Delayed gross motor development (HP:0002194) | 1.93831918 |
| 89 | Dysdiadochokinesis (HP:0002075) | 1.93214501 |
| 90 | Delusions (HP:0000746) | 1.93159810 |
| 91 | Spastic tetraplegia (HP:0002510) | 1.93085786 |
| 92 | Dysmetria (HP:0001310) | 1.92320817 |
| 93 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89868563 |
| 94 | Menstrual irregularities (HP:0000858) | 1.89277450 |
| 95 | Retinal dysplasia (HP:0007973) | 1.88467479 |
| 96 | Shoulder girdle muscle weakness (HP:0003547) | 1.87482689 |
| 97 | Inability to walk (HP:0002540) | 1.87198208 |
| 98 | Mutism (HP:0002300) | 1.87081830 |
| 99 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.86728602 |
| 100 | Molar tooth sign on MRI (HP:0002419) | 1.86202358 |
| 101 | Abnormality of midbrain morphology (HP:0002418) | 1.86202358 |
| 102 | Pachygyria (HP:0001302) | 1.85892320 |
| 103 | Methylmalonic aciduria (HP:0012120) | 1.84470291 |
| 104 | Intestinal atresia (HP:0011100) | 1.84470068 |
| 105 | Abnormality of the corticospinal tract (HP:0002492) | 1.84313431 |
| 106 | Cerebral edema (HP:0002181) | 1.83753653 |
| 107 | Poor eye contact (HP:0000817) | 1.83232543 |
| 108 | Bradykinesia (HP:0002067) | 1.82530565 |
| 109 | Insidious onset (HP:0003587) | 1.82441842 |
| 110 | Termporal pattern (HP:0011008) | 1.82441842 |
| 111 | Poor coordination (HP:0002370) | 1.82385141 |
| 112 | Congenital stationary night blindness (HP:0007642) | 1.82210221 |
| 113 | Optic nerve hypoplasia (HP:0000609) | 1.81511245 |
| 114 | X-linked dominant inheritance (HP:0001423) | 1.81282897 |
| 115 | Ketoacidosis (HP:0001993) | 1.79286112 |
| 116 | Spastic gait (HP:0002064) | 1.78620865 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.78374626 |
| 118 | Cerebral hypomyelination (HP:0006808) | 1.77903645 |
| 119 | Hyperglycinemia (HP:0002154) | 1.77259342 |
| 120 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.76254357 |
| 121 | Hypoplasia of the brainstem (HP:0002365) | 1.76254357 |
| 122 | Fetal akinesia sequence (HP:0001989) | 1.75252113 |
| 123 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75157474 |
| 124 | Exercise intolerance (HP:0003546) | 1.75071489 |
| 125 | Amyotrophic lateral sclerosis (HP:0007354) | 1.74898120 |
| 126 | Sleep apnea (HP:0010535) | 1.73494012 |
| 127 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.72768824 |
| 128 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.72768824 |
| 129 | Hypoglycemic coma (HP:0001325) | 1.72566365 |
| 130 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.72366838 |
| 131 | Restlessness (HP:0000711) | 1.72174133 |
| 132 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71855635 |
| 133 | Focal dystonia (HP:0004373) | 1.70127120 |
| 134 | Abnormality of renal resorption (HP:0011038) | 1.69020155 |
| 135 | Sclerocornea (HP:0000647) | 1.69001862 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.68959415 |
| 137 | Hypoglycemic seizures (HP:0002173) | 1.68705313 |
| 138 | Hypomagnesemia (HP:0002917) | 1.67250983 |
| 139 | Torticollis (HP:0000473) | 1.66599282 |
| 140 | Hyperphosphaturia (HP:0003109) | 1.64268101 |
| 141 | Growth hormone deficiency (HP:0000824) | 1.61861312 |
| 142 | Abnormality of urine glucose concentration (HP:0011016) | 1.61223822 |
| 143 | Glycosuria (HP:0003076) | 1.61223822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.08688896 |
| 2 | MAP3K12 | 3.66034114 |
| 3 | CASK | 3.18598591 |
| 4 | MAP3K4 | 3.14653337 |
| 5 | MAP3K9 | 3.14279513 |
| 6 | MARK1 | 3.03487661 |
| 7 | PNCK | 2.92112645 |
| 8 | MAP2K7 | 2.74117672 |
| 9 | EPHA4 | 2.56232505 |
| 10 | MINK1 | 2.54741514 |
| 11 | MAP4K2 | 2.54157450 |
| 12 | FRK | 2.39445864 |
| 13 | ARAF | 2.39064090 |
| 14 | PINK1 | 2.31092173 |
| 15 | NTRK2 | 2.13231706 |
| 16 | GRK5 | 2.07377379 |
| 17 | MAP2K4 | 2.04079210 |
| 18 | MAPK13 | 1.85356942 |
| 19 | NTRK1 | 1.80057122 |
| 20 | UHMK1 | 1.72146160 |
| 21 | NME1 | 1.71890959 |
| 22 | TRIM28 | 1.68935757 |
| 23 | PLK2 | 1.62683663 |
| 24 | TNIK | 1.58942041 |
| 25 | DAPK2 | 1.52920951 |
| 26 | GRK7 | 1.46110282 |
| 27 | KSR2 | 1.39203005 |
| 28 | KSR1 | 1.32874683 |
| 29 | CDK5 | 1.32723283 |
| 30 | WNK3 | 1.32416732 |
| 31 | PAK6 | 1.31861540 |
| 32 | DAPK1 | 1.30524669 |
| 33 | FGFR2 | 1.25100461 |
| 34 | BCR | 1.24440308 |
| 35 | PRKCG | 1.23710634 |
| 36 | CAMK2A | 1.21789881 |
| 37 | CDK19 | 1.20258378 |
| 38 | ADRBK2 | 1.16993404 |
| 39 | SIK3 | 1.15671515 |
| 40 | GRK1 | 1.12737259 |
| 41 | CAMK2B | 1.10609195 |
| 42 | CAMKK2 | 1.04198880 |
| 43 | CSNK1G2 | 1.02648046 |
| 44 | CSNK1A1L | 0.99880451 |
| 45 | CDK14 | 0.99286300 |
| 46 | CDK18 | 0.97547397 |
| 47 | PAK3 | 0.97451642 |
| 48 | FES | 0.95798474 |
| 49 | BRAF | 0.94281529 |
| 50 | ADRBK1 | 0.93486934 |
| 51 | RIPK4 | 0.92313005 |
| 52 | CDK15 | 0.91126095 |
| 53 | CSNK1G3 | 0.90574933 |
| 54 | MAPKAPK5 | 0.90479881 |
| 55 | SIK2 | 0.90360603 |
| 56 | PHKG2 | 0.90039427 |
| 57 | PHKG1 | 0.90039427 |
| 58 | BCKDK | 0.87143078 |
| 59 | MAP3K2 | 0.86224095 |
| 60 | OXSR1 | 0.85755748 |
| 61 | ZAK | 0.84796807 |
| 62 | MKNK2 | 0.83362059 |
| 63 | DYRK3 | 0.82580333 |
| 64 | WNK4 | 0.80447254 |
| 65 | CDK11A | 0.80439825 |
| 66 | CAMK2D | 0.79615493 |
| 67 | TSSK6 | 0.77896888 |
| 68 | DYRK1A | 0.76738291 |
| 69 | LATS2 | 0.75078565 |
| 70 | AKT3 | 0.74080141 |
| 71 | BMPR1B | 0.73463608 |
| 72 | PRKCE | 0.71142647 |
| 73 | INSRR | 0.69883664 |
| 74 | SGK494 | 0.69501203 |
| 75 | SGK223 | 0.69501203 |
| 76 | CAMK2G | 0.68127620 |
| 77 | PRPF4B | 0.67124987 |
| 78 | CAMKK1 | 0.66735517 |
| 79 | BMPR2 | 0.66569674 |
| 80 | MAPK15 | 0.66049945 |
| 81 | MAP3K13 | 0.64864691 |
| 82 | PRKD3 | 0.63393264 |
| 83 | LIMK1 | 0.62490284 |
| 84 | NUAK1 | 0.61010874 |
| 85 | PLK3 | 0.59762904 |
| 86 | PKN1 | 0.59091601 |
| 87 | TAOK3 | 0.58538004 |
| 88 | STK16 | 0.58272331 |
| 89 | DYRK2 | 0.58144083 |
| 90 | FER | 0.57719296 |
| 91 | PRKCH | 0.56211399 |
| 92 | FGR | 0.54270128 |
| 93 | CAMK1 | 0.52605371 |
| 94 | PTK2B | 0.52567347 |
| 95 | CSNK1A1 | 0.52387398 |
| 96 | TYRO3 | 0.51671285 |
| 97 | EPHA3 | 0.51223779 |
| 98 | VRK1 | 0.51026464 |
| 99 | PRKACA | 0.49586538 |
| 100 | PASK | 0.48581502 |
| 101 | CAMK1G | 0.47665701 |
| 102 | PRKG1 | 0.47529815 |
| 103 | RET | 0.47288389 |
| 104 | TNK2 | 0.45962713 |
| 105 | CSNK1G1 | 0.45928252 |
| 106 | MAP3K1 | 0.45904494 |
| 107 | MAP2K1 | 0.44748825 |
| 108 | RAF1 | 0.44475280 |
| 109 | STK39 | 0.44448550 |
| 110 | PRKACB | 0.43842639 |
| 111 | MAP2K6 | 0.42581762 |
| 112 | CDK3 | 0.41350758 |
| 113 | SGK1 | 0.41248318 |
| 114 | STK11 | 0.41172166 |
| 115 | CSNK1D | 0.40877637 |
| 116 | SGK2 | 0.39798108 |
| 117 | PRKCZ | 0.39792050 |
| 118 | PRKCA | 0.38937785 |
| 119 | CSNK1E | 0.38750183 |
| 120 | MKNK1 | 0.37969471 |
| 121 | MUSK | 0.37934061 |
| 122 | RPS6KA2 | 0.37262694 |
| 123 | RPS6KA5 | 0.36280590 |
| 124 | ERBB3 | 0.35538687 |
| 125 | MYLK | 0.35200041 |
| 126 | RPS6KA3 | 0.34658347 |
| 127 | MARK2 | 0.34486269 |
| 128 | SRPK1 | 0.34419164 |
| 129 | ALK | 0.34379812 |
| 130 | PRKCB | 0.33596434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.90392478 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.72078576 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.64779246 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.10099151 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.97221576 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.62027523 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.61641753 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.52151222 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38947241 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.26107258 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.24478734 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23206373 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17086725 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.16188542 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.14180717 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.11473619 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 2.06503026 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 2.05521954 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04185899 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.03927156 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.00876727 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.97420335 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82516891 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.78349387 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67918984 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.62714955 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.60421761 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.57658733 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.52687175 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.52431272 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45204842 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34888709 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31343781 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29788377 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.22060146 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21249172 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.20838087 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.20195141 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.17679119 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13473992 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10471604 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07629406 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.05258950 |
| 44 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03473199 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02072558 |
| 46 | Ribosome_Homo sapiens_hsa03010 | 1.01611427 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92434304 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90437054 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90112185 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.87818931 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.86267040 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84068210 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81624259 |
| 54 | Alcoholism_Homo sapiens_hsa05034 | 0.80677358 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79141385 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78691322 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78402889 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78238047 |
| 59 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77458567 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77372970 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77093231 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76811141 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.74614077 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74089227 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73270604 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72682709 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70098969 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66889732 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66427238 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.65595296 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65026236 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65023316 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64747260 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64743970 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64726557 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63537253 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63122536 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62653252 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58565767 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58445751 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58058181 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54679248 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53849391 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.53673207 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.53389710 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53336841 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53114331 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52918031 |
| 89 | Proteasome_Homo sapiens_hsa03050 | 0.52917748 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52718054 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.52061720 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51547481 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.51339704 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49923712 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48302706 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.46721143 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46473168 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45461789 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42573316 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40008153 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38071758 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35232825 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35152548 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34806901 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34628661 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33253551 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33196274 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31716195 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30867021 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30138562 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30007492 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29968507 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28814013 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27580914 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26382923 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25452941 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23715391 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23375429 |
| 119 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.23066143 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23059331 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22439007 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22407516 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22066211 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21928786 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20960663 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17942910 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17846426 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17500030 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.17287969 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16832598 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15738095 |

